Sort
23,748 grants matching “melanoma”
Thrombocytes in Cancer Immunity
$225,092Zihai Li · Ohio State University · R01 · FY2019 · CA
An Intelligent Melanoma Diagnostic Training System
$225,005University Of Pittsburgh At Pittsburgh · R25 · FY2005 · CA
A Novel Immunotolerizing Therapy for Autoimmune Vitiligo
$225,000Andrew L Salzman · Radikal Therapeutics, Inc. · R43 · FY2014 · AR
Co-targeting Ezh2 with PD1 to improve T cell exhaustion reversal and tumor responses
$225,000Mumtaz Yaseen Balkhi · It Bio, Llc · R43 · FY2019 · CA
beta-Catenin inhibitors: A novel immuno-therapy for Colorectal Cancer
$225,000Shantha T Raju · Venn Therapeutics, Llc · R43 · FY2019 · CA
Mechanisms of augmented UVB immunosuppressive responses by polyaromatic hydrocarbons
$225,000Ravi Prakash Sahu · Wright State University · R21 · FY2022 · ES
Enable Early and Sensitive In Vivo Detection of Liver Metastasis by Protein-based
$225,000Jenny J Yang · Inlighta Biosciences, Llc · R41 · FY2014 · CA
Commitment and Plasticity of Th17 cells and Tregs in the Tumor Microenvironment
$225,000Guangyong Peng · Saint Louis University · R21 · FY2012 · AI
Multiplexed Mapping of Immune Infiltrates
$225,000Mark S. Chee · Prognosys Biosciences, Inc. · R43 · FY2014 · CA
In-Situ Autovaccination against Solid Cancers with Intratumoral Hiltonol (Poly-ICLC): A phase II Adaptive Multicenter Clinical Study
$225,000Andres Mario Salazar · Oncovir, Inc. · R44 · FY2014 · CA
Development of a Biologically-based Nursing Intervention for Cancer Cachexia
$225,000Donna O McCarthy-Beckett · Ohio State University · R15 · FY2009 · NR
DEVELOPMENTAL BASES FOR PIGMENT CELL VARIATION IN DANIO
$225,000University Of Texas Austin · R01 · FY2004 · GM
Ubiquitination in Immune Tolerance
$225,000Yun-Cai Liu · La Jolla Institute For Immunology · R21 · FY2019 · AI
Inhibition of UVB-induced inflammation and carcinogenesis by black raspberry extr
$225,000Tatiana M Oberyszyn · Ohio State University · R21 · FY2007 · AT
DEVELOPMENTAL BASES FOR PIGMENT CELL VARIATION IN DANIO
$225,000University Of Texas Austin · R01 · FY2002 · GM
STTR Phase I: Purification of Mycosporine-like Amino Acids using Aptamers
$225,000David T Smernoff · Heliobiosys, Inc · · FY2020 · TIP
DEVELOPMENTAL BASES FOR PIGMENT CELL VARIATION IN DANIO
$225,000University Of Texas Austin · R01 · FY2003 · GM
Small-molecule agonists of the RIG-I-like receptor pathway as cancer immunotherapeutics
$225,000Peter Probst · Kineta, Inc. · R43 · FY2018 · CA
IL2-based Immunotherapy for Lupus
$225,000Ridong Chen · Apt Therapeutics, Inc. · R43 · FY2016 · AR
DEVELOPMENTAL BASES FOR PIGMENT CELL VARIATION IN DANIO
$225,000University Of Texas Austin · R01 · FY2005 · GM
Predevelopment of VV2003, a Novel CRAC Channel Inhibitor, to Improve Outcomes Associated with Checkpoint Inhibitor Immunotherapy
$225,000Milton L Greenberg · Vivreon Biosciences, Llc · R43 · FY2018 · CA
Small molecule ubiquitin ligase modulators for immunotherapy of cancer
$224,995Kumar Suresh · Progenra, Inc. · R43 · FY2017 · CA
Novel targeted therapeutic for advanced metastatic disease
$224,981Bo Yu · Larix Bioscience, Llc · R43 · FY2017 · CA
Handheld Two-Photon Microscopy Imager
$224,980Youbo Zhao · Physical Sciences, Inc · R43 · FY2017 · CA
Molecular and Cellular Oncology Research Program
$224,974Rina Plattner · University Of Kentucky · P30 · FY2023 · CA